Trial Profile
A pilot study to assess the efficacy and safety of LCQ908 alone and in combination with fenofibrate or Lovaza® in patients with severe hypertriglyceridemia [Multicentrická, randomizovaná, placebem kontrolovaná, dvojitě zaslepená pilotní studie s aktivním komparátorem k vyhodnocení účinnosti a bezpečnosti LCQ908, samostatně a v kombinaci s fenofibrátem nebo přípravkem Lovaza® u pacientů s těžkou hypertriglyceridémií].
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Pradigastat (Primary) ; Fenofibrate; Omega-3-acid ethyl esters
- Indications Hypertriglyceridaemia
- Focus Therapeutic Use
- 01 Jul 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 12 Jan 2013 New source identified and integrated (European Clinical Trials Database record: EudraCT2012-000872-40).
- 01 Aug 2012 Actual initiation date (Jun 2012) added as reported by ClinicalTrials.gov.